Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta Plus Atomoxetine in Children and Adolescents With ADHD
NCT00585910Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Primary endpoint: Attention Deficit Hyperactivity Disorder Rating Scale at 7 weeks. Started Jan 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00585910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585910.